State attorneys general honed in on another segment of the generic drug industry, topical products, in their third suit alleging manufacturers and individual executives engaged in an overarching conspiracy to allocate markets and fix prices.
The allegations in the 593-page complaint, filed 10 June in the US District Court for the District of Connecticut,...







